Cargando…

Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge

OBJECTIVE: We describe the novel case of a patient presenting with pulmonary mucosa-associated lymphoid tissue lymphoma (pMALToma) synchronous with metastatic prostate adenocarcinoma. MATERIALS AND METHODS: We report the clinical, laboratory, radiological and histological findings of the above patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Braddy, Aaron, Mogal, Rahul Janardan, Maddox, Anthony John, Barlow, Andrew Bryan Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417046/
https://www.ncbi.nlm.nih.gov/pubmed/32789141
http://dx.doi.org/10.12890/2020_001711
_version_ 1783569412248305664
author Braddy, Aaron
Mogal, Rahul Janardan
Maddox, Anthony John
Barlow, Andrew Bryan Timothy
author_facet Braddy, Aaron
Mogal, Rahul Janardan
Maddox, Anthony John
Barlow, Andrew Bryan Timothy
author_sort Braddy, Aaron
collection PubMed
description OBJECTIVE: We describe the novel case of a patient presenting with pulmonary mucosa-associated lymphoid tissue lymphoma (pMALToma) synchronous with metastatic prostate adenocarcinoma. MATERIALS AND METHODS: We report the clinical, laboratory, radiological and histological findings of the above patient. RESULTS: While the patient’s metastatic prostate adenocarcinoma responded well to chemo-radio-hormonal therapy, a persistent area of lung consolidation was noted and further investigated, leading to the diagnosis of concurrent pMALToma. CONCLUSION: It is important to pursue further investigation when there appears to be persistent change or altered disease response in malignancy if there is evidence for disease response elsewhere, as there may be two synchronous primary cancers. LEARNING POINTS: This is a novel case where pulmonary mucosa-associated lymphoid tissue lymphoma (pMALToma), a rare disease entity, presented synchronously and asymptomatically in a patient with metastatic prostate adenocarcinoma. From an instructive errors perspective, it is important to consider synchronous primary malignancy and pursue further investigations, as appropriate, when there appears to be persistent change or altered disease response if there is evidence for disease response elsewhere;
format Online
Article
Text
id pubmed-7417046
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SMC Media Srl
record_format MEDLINE/PubMed
spelling pubmed-74170462020-08-11 Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge Braddy, Aaron Mogal, Rahul Janardan Maddox, Anthony John Barlow, Andrew Bryan Timothy Eur J Case Rep Intern Med Articles OBJECTIVE: We describe the novel case of a patient presenting with pulmonary mucosa-associated lymphoid tissue lymphoma (pMALToma) synchronous with metastatic prostate adenocarcinoma. MATERIALS AND METHODS: We report the clinical, laboratory, radiological and histological findings of the above patient. RESULTS: While the patient’s metastatic prostate adenocarcinoma responded well to chemo-radio-hormonal therapy, a persistent area of lung consolidation was noted and further investigated, leading to the diagnosis of concurrent pMALToma. CONCLUSION: It is important to pursue further investigation when there appears to be persistent change or altered disease response in malignancy if there is evidence for disease response elsewhere, as there may be two synchronous primary cancers. LEARNING POINTS: This is a novel case where pulmonary mucosa-associated lymphoid tissue lymphoma (pMALToma), a rare disease entity, presented synchronously and asymptomatically in a patient with metastatic prostate adenocarcinoma. From an instructive errors perspective, it is important to consider synchronous primary malignancy and pursue further investigations, as appropriate, when there appears to be persistent change or altered disease response if there is evidence for disease response elsewhere; SMC Media Srl 2020-06-01 /pmc/articles/PMC7417046/ /pubmed/32789141 http://dx.doi.org/10.12890/2020_001711 Text en © EFIM 2020 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Articles
Braddy, Aaron
Mogal, Rahul Janardan
Maddox, Anthony John
Barlow, Andrew Bryan Timothy
Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge
title Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge
title_full Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge
title_fullStr Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge
title_full_unstemmed Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge
title_short Pulmonary MALToma Synchronous with Metastatic Prostate Adenocarcinoma: A Diagnostic Challenge
title_sort pulmonary maltoma synchronous with metastatic prostate adenocarcinoma: a diagnostic challenge
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417046/
https://www.ncbi.nlm.nih.gov/pubmed/32789141
http://dx.doi.org/10.12890/2020_001711
work_keys_str_mv AT braddyaaron pulmonarymaltomasynchronouswithmetastaticprostateadenocarcinomaadiagnosticchallenge
AT mogalrahuljanardan pulmonarymaltomasynchronouswithmetastaticprostateadenocarcinomaadiagnosticchallenge
AT maddoxanthonyjohn pulmonarymaltomasynchronouswithmetastaticprostateadenocarcinomaadiagnosticchallenge
AT barlowandrewbryantimothy pulmonarymaltomasynchronouswithmetastaticprostateadenocarcinomaadiagnosticchallenge